CALIFORNIA HOSPITAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.1M
- Transactions
- 131
- Companies
- 24
- Average per transaction
- $8,286
Who reported the payments
| CSL Behring | $495,459 |
| Merck | $204,963 |
| Regeneron | $105,525 |
| Si-bone, Inc. | $68,402 |
| Davol Inc. | $67,373 |
| Agios Pharmaceuticals, Inc. | $31,215 |
| Stryker | $24,805 |
| Boston Scientific | $14,444 |
| Lemaitre Vascular, Inc. | $14,099 |
| Servier Pharmaceuticals LLC | $9,144 |
| Nevro Corp. | $8,460 |
| Siemens Medical Solutions USA, Inc. | $8,305 |
| Bio-rad Laboratories, Inc. | $6,348 |
| Zimmer Biomet | $5,842 |
| Bard Peripheral Vascular, Inc. | $4,135 |
| Bristol Myers Squibb | $4,094 |
| Microvention, Inc. | $3,200 |
| Sage Therapeutics, LLC | $2,250 |
| ZOLL Circulation Inc | $2,000 |
| Johnson & Johnson | $1,500 |
| Poriferous LLC | $1,500 |
| Hikma Pharmaceuticals USA | $1,378 |
| Baxter Healthcare | $569 |
| Surmodics, Inc. | $500 |